Page 2583 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 2583

Chapter 158  Hematologic Aspects of Parasitic Diseases  2303.e3


             97.  Fried M, Duffy PE: Adherence of Plasmodium falciparum to chondroi-  122.  Dondorp  AM,  Fanello  CI,  Hendriksen  IC,  et al:  Artesunate  versus
                tin sulfate A in the human placenta. Science 272:1502, 1996.  quinine in the treatment of severe falciparum malaria in African chil-
             98.  Beeson JG, Rogerson SJ, Cooke BM, et al: Adhesion of Plasmodium   dren (AQUAMAT): an open-label, randomised trial. Lancet 376:1647,
                falciparum-infected erythrocytes to hyaluronic acid in placental malaria.   2010.
                Nat Med 6:86, 2000.                               123.  Njuguna P, Newton C: Management of severe falciparum malaria. J
             99.  Rogerson SJ, Hviid L, Duffy PE, et al: Malaria in pregnancy: patho-  Postgrad Med 50:45, 2004.
                genesis and immunity. Lancet Infect Dis 7:105, 2007.  124.  Dhabangi  A,  Ainomugisha  B,  Cserti-Gazdewich  C,  et al:  Effect  of
            100.  Guyatt  HL,  Snow  RW:  Malaria  in  pregnancy  as  an  indirect  cause   transfusion of red blood cells with longer vs shorter storage duration on
                of infant mortality in sub-Saharan Africa. Trans R Soc Trop Med Hyg   elevated blood lactate levels in children with severe anemia: the TOTAL
                95:569, 2001.                                         randomized clinical trial. JAMA 314:2514–2523, 2015.
            101.  ter Kuile FO, van Eijk AM, Filler SJ: Effect of sulfadoxine-pyrimethamine   125.  Newton CR, Krishna S: Severe falciparum malaria in children: current
                resistance on the efficacy of intermittent preventive therapy for malaria   understanding of pathophysiology and supportive treatment. Pharmacol
                control during pregnancy: a systematic review. JAMA 297:2603, 2007.  Ther 79:1, 1998.
            102.  Bedu-Addo  G,  Bates  I:  Causes  of  massive  tropical  splenomegaly  in   126.  Riddle  MS,  Jackson  JL,  Sanders  JW,  et al:  Exchange  transfusion  as
                Ghana. Lancet 360:449, 2002.                          an adjunct therapy in severe Plasmodium falciparum malaria: a meta-
            103.  Zhu D, Thompsett AR, Bedu-Addo G, et al: VH gene sequences from   analysis. Clin Infect Dis 34:1192, 2002.
                a novel tropical splenic lymphoma reveal a naive B cell as the cell of   127.  Bruce-Chwatt LJ: Transfusion malaria revisited. Trop Dis Bull 79:827,
                origin. Br J Haematol 107:114, 1999.                  1982.
            104.  Price RN, Douglas NM, Anstey NM: New developments in Plasmo-  128.  Schlagenhauf  P,  Mueutener  P:  Imported  malaria.  In  Schlagenhauf-
                dium vivax malaria: severe disease and the rise of chloroquine resistance.   Lawlor P, editor: Traveler’s malaria, Hamilton, ON, 2001, BC Decker
                Curr Opin Infect Dis 22:430, 2009.                    Inc., p 495.
            105.  Nosten F, McGready R, Simpson JA, et al: Effects of Plasmodium vivax   129.  De  Silva  M,  Contreras  M,  Barbara  J:  Two  cases  of  transfusion-
                malaria in pregnancy. Lancet 354:546, 1999.           transmitted malaria (TTM) in the UK [letter]. Transfusion 28:86, 1988.
            106.  Gilles HM, Hendrickse RG: Possible aetiological role of Plasmodium   130.  Chiodini  PL,  Hartley  S,  Hewitt  PE,  et al:  Evaluation  of  a  malaria
                malariae in “nephrotic syndrome” in Nigerian children. Lancet 1:806,   antibody ELISA and its value in reducing potential wastage of red cell
                1960.                                                 donations from blood donors exposed to malaria, with a note on a case
            107.  Warhurst  DC,  Williams  JE:  Laboratory  diagnosis  of  malaria—ACP   of transfusion-transmitted malaria. Vox Sang 73:143, 1997.
                Broadsheet No. 148. J Clin Pathol 49:533, 1996.   131.  Kitchen  A,  Mijovic  A,  Hewitt  P:  Transfusion-transmitted  malaria:
            108.  Lewis SM, Bain BJ, Bates I: Dacie and Lewis practical haematology, ed   current donor selection guidelines are not sufficient. Vox Sang 88:200,
                10, Edinburgh, UK, 2005, Churchill Livingstone.       2005.
            109.  Bailey JW, Williams J, Bain BJ, et al: Guideline: the laboratory diagnosis   132.  Mungai  M,  Tegtmeier  G,  Chamberland  M,  et al:  Transfusion-
                of malaria. Br J Haematol 163(5):573, 2013. doi:10.1111/bjh.12572.  transmitted malaria in the United States from 1963 through 1999. N
            110.  Moody A: Rapid diagnostic tests for malaria parasites. Clin Microbiol   Engl J Med 344:1973, 2001.
                Rev 15:66, 2002.                                  133.  Mali  S,  Tan  KR,  Arguin  PM:  Malaria  surveillance—United  States,
            111.  Milne LM, Kyi MS, Chiodini PL, et al: Accuracy of routine laboratory   2009. MMWR Surveill Summ 60:1, 2011.
                diagnosis  of  malaria  in  the  United  Kingdom.  J  Clin  Pathol  47:740,   134.  Kitchen  AD,  Barbara  JA,  Hewitt  PE:  Documented  cases  of  post-
                1994.                                                 transfusion malaria occurring in England: a review in relation to current
            112.  Baird  JK,  Purnomo,  Jones TR:  Diagnosis  of  malaria  in  the  field  by   and proposed donor-selection guidelines. Vox Sang 89:77, 2005.
                fluorescence microscopy of QBC capillary tubes. Trans R Soc Trop Med   135.  Kitchen  AD,  Lowe  PH,  Lalloo  K,  et al:  Evaluation  of  a  malarial
                Hyg 86:3, 1992.                                       antibody assay for use in the screening of blood and tissue products
            113.  Benito  A,  Roche  J,  Molina  R,  et al:  Application  and  evaluation  of   for clinical use. Vox Sang 87:150, 2004.
                QBC malaria diagnosis in a holoendemic area. Appl Parasitol 35:266,   136.  Slinger R, Giulivi A, Bodie-Collins M, et al: Transfusion-transmitted
                1994.                                                 malaria in Canada. CMAJ 164:377, 2001.
            114.  Bosch I, Bracho C, Perez HA: Diagnosis of malaria by acridine orange   137.  Alvar J, Velez ID, Bern C, et al: Leishmaniasis worldwide and global
                fluorescent  microscopy  in  an  endemic  area  of  Venezuela.  Mem  Inst   estimates of its incidence. PLoS ONE 7:e35671, 2012.
                Oswaldo Cruz 91:83, 1996.                         138.  Ross  R:  Note  on  the  bodies  recently  described  by  Leishman  and
            115.  Huong NM, Davis TM, Hewitt S, et al: Comparison of three antigen   Donovan. Br Med J 2:1261, 1903.
                detection methods for diagnosis and therapeutic monitoring of malaria:   139.  Garnham  PC: The  leishmanias,  with  special  reference  to  the  role  of
                a  field  study  from  southern  Vietnam.  Trop  Med  Int  Health  7:304,   animal reservoirs. Am Zool 5:141, 1965.
                2002.                                             140.  Symmers WS: Leishmaniasis acquired by contagion: a case of marital
            116.  Lalloo DG, Shingadia D, Bell DJ, et al: UK malaria treatment guide-  infection in Britain. Lancet 1:127, 1960.
                lines 2016. J Infect 72:635–649, 2016.            141.  Campino L, Santos-Gomes G, Pratlong F, et al: The isolation of Leish-
            117.  McNamara DT, Thomson JM, Kasehagen LJ, et al: Development of a   mania donovani MON-18, from an AIDS patient in Portugal: possible
                multiplex PCR-ligase detection reaction assay for diagnosis of infection   needle transmission. Parasite 1:391, 1994.
                by the four parasite species causing malaria in humans. J Clin Microbiol   142.  Sampaio MJ, Cavalcanti NV, Alves JG, et al: Risk factors for death in
                42:2403, 2004.                                        children with visceral leishmaniasis. PLoS Negl Trop Dis 4:e877, 2010.
            118.  Rubio JM, Benito A, Berzosa PJ, et al: Usefulness of seminested multi-  143.  Badaro  R,  Jones  TC,  Carvalho  EM,  et al:  New  perspectives  on  a
                plex PCR in surveillance of imported malaria in Spain. J Clin Microbiol   subclinical form of visceral leishmaniasis. J Infect Dis 154:1003, 1986.
                37:3260, 1999.                                    144.  Magill AJ, Grogl M, Gasser RA, Jr, et al: Visceral infection caused by
            119.  Benito A, Rubio JM: Usefulness of seminested polymerase chain reac-  Leishmania tropica in veterans of Operation Desert Storm. N Engl J
                tion for screening blood donors at risk for malaria in Spain. Emerg Infect   Med 328:1383, 1993.
                Dis 7:1068, 2001.                                 145.  Pratlong F, Dedet JP, Marty P, et al: Leishmania-human immunode-
            120.  WorldWide  Antimalarial  Resistance  Network  (WWARN)  Lumefan-  ficiency  virus  coinfection  in  the  Mediterranean  basin:  isoenzymatic
                trine  PK/PD  Study  Group:  Artemether-lumefantrine  treatment  of   characterization of 100 isolates of the Leishmania infantum complex. J
                uncomplicated Plasmodium falciparum malaria: a systematic review and   Infect Dis 172:323, 1995.
                meta-analysis  of  day  7  lumefantrine  concentrations  and  therapeutic   146.  Alvar J, Canavate C, Gutierrez-Solar B, et al: Leishmania and human
                response using individual patient data. BMC Med 13:227, 2015.  immunodeficiency virus coinfection: the first 10 years. Clin Microbiol
            121.  Woodrow CJ, White NJ: The clinical impact of artemisinin resistance   Rev 10:298, 1997.
                in Southeast Asia and the potential for future spread. FEMS Microbiol   147.  Ramos-Santos  C,  Hernandez-Montes  O,  Sanchez-Tejeda  G,  et al:
                Rev 41:34, 2017.                                      Visceral leishmaniosis caused by Leishmania (L.) mexicana in a Mexican
   2578   2579   2580   2581   2582   2583   2584   2585   2586   2587   2588